ANGLE plc

Surrey, Canada Founded: 1994 • Age: 32 yrs
ANGLE plc is focused on liquid biopsy for cancer research.

About ANGLE plc

ANGLE plc is a company based in Surrey (Canada) founded in 1994. It operates as a HealthTech, and Professional Services. The company has 119 employees as of December 31, 2024. ANGLE plc offers products and services including Parsortix PC1 System, Parsortix PR1 System, Portrait+ CTC Staining Kit, and Laboratory Services. ANGLE plc operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.

  • Headquarter Surrey, Canada
  • Employees 119 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cellbxhealth Plc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $3.58 M (USD)
    30.92
    as on Dec 31, 2024
  • Net Profit
    $-17.82 M (USD)
    29.34
    as on Dec 31, 2024
  • EBITDA
    $-17.27 M (USD)
    24.1
    as on Dec 31, 2024
  • Latest Funding Round
    $23.67 M (USD), Post-IPO

    Jul 15, 2022

  • Investors
  • Employee Count
    119

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of ANGLE plc

ANGLE plc is a publicly listed company on the LSE with ticker symbol AGL in UK, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: LSE · Ticker: AGL . Sector: Distribution services · UK

Products & Services of ANGLE plc

ANGLE plc offers a comprehensive portfolio of products and services, including Parsortix PC1 System, Parsortix PR1 System, Portrait+ CTC Staining Kit, and Laboratory Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Automated system for capturing circulating tumor cells used.

Research system for circulating tumor cell harvesting provided.

Kit for staining circulating tumor cells in analysis.

Custom CTC analysis services for research are offered.

People of ANGLE plc
Headcount 50-200
Employee Profiles 26
Board Members and Advisors 11
Employee Profiles
People
Ghada Abuali
Business Solutions & Strategy Director
People
Michelle Munson
HR Director
People
Ian Griffiths
Chief Financial Officer
People
Andrew Newland
Chief Executive

Unlock access to complete

Board Members and Advisors
people
Ashok Venkitaraman
Scientific Advisor
people
James Reuben
Scientific Advisor
people
Jan Groen
Chairman
people
Brian Howlett
Non-executive Director & Senior Independent Director

Unlock access to complete

Funding Insights of ANGLE plc

  • Total Funding
  • Total Rounds 6
  • Last Round Post-IPO — $23.7M
  • First Round

    (26 Feb 2015)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2022 Amount Post-IPO - ANGLE plc Valuation

investors

Oct, 2020 Amount Post-IPO - ANGLE plc Valuation

investors

Jun, 2018 Amount Post-IPO - ANGLE plc Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ANGLE plc

ANGLE plc has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ANGLE plc

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ANGLE plc

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Angle Plc Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ANGLE plc

ANGLE plc operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Digital sequencing technology for cancer detection is developed.
domain founded_year HQ Location
Developer of cell-free DNA testing for oncology, women’s health, and organ health
domain founded_year HQ Location
Genomics-based diagnostic tests for cancer are provided.
domain founded_year HQ Location
Molecular cancer diagnostic products are developed using patented AMP technology.
domain founded_year HQ Location
Health risks are identified through online genetic and diagnostic testing.
domain founded_year HQ Location
Blood-based liquid biopsy tests for multiple cancer detection are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Angle Plc

Frequently Asked Questions about ANGLE plc

When was ANGLE plc founded?

ANGLE plc was founded in 1994 and raised its 1st funding round 21 years after it was founded.

Where is ANGLE plc located?

ANGLE plc is headquartered in Surrey, Canada. It is registered at Surrey, British Columbia, Canada.

How many employees does ANGLE plc have?

As of Dec 31, 2024, the latest employee count at ANGLE plc is 119.

What is the annual revenue of ANGLE plc?

Annual revenue of ANGLE plc is $3.58M as on Dec 31, 2024.

What does ANGLE plc do?

ANGLE plc is engaged in developing liquid biopsy solutions for cancer diagnosis, prognosis, and treatment. The company specializes in circulating tumor cell (CTC) harvesting through its proprietary Parsortix technology, which is utilized in clinical and research settings. Solutions are provided for various cancer types, including breast, prostate, ovarian, lung, and glioblastoma. Laboratory services are offered globally to support biopharmaceutical and translational research. The focus is placed on precision medicine by enabling downstream analysis of CTCs for personalized treatment approaches.

Who are the top competitors of ANGLE plc?

ANGLE plc's top competitors include Guardant Health, Foundation Medicine and Natera.

What products or services does ANGLE plc offer?

ANGLE plc offers Parsortix PC1 System, Parsortix PR1 System, Portrait+ CTC Staining Kit, and Laboratory Services.

Is ANGLE plc publicly traded?

Yes, ANGLE plc is publicly traded on LSE under the ticker symbol AGL.

Who are ANGLE plc's investors?

ANGLE plc has 1 investor. Key investors include European Union.

What is ANGLE plc's ticker symbol?

The ticker symbol of ANGLE plc is AGL on LSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available